All News #Library
Biotech
BioLineRx, Hemispherian Dose First Patient in GBM Study
28 Apr 2026 //
PR NEWSWIRE
Tempus, NYU Langone Health Partner To Advance Precision Oncology
12 Jan 2026 //
BUSINESSWIRE
Genprex Signs Exclusive License Agreement with NYU for Mesothelioma
28 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support